ISCHEMIC AND HEMORRHAGIC STROKE: CONTEMPORARY PATHOPHYSIOLOGY, DIAGNOSIS, AND EVIDENCE-BASED MANAGEMENT

Authors

  • Tosheva Marjona Abdusalomovna Department of Clinical Sciences, Asia International University, Bukhara, Uzbekistan

Keywords:

stroke; cerebrovascular disease; ischemic stroke; intracerebral hemorrhage; thrombolysis; endovascular thrombectomy; secondary prevention

Abstract

Stroke remains one of the leading causes of death and long-term disability worldwide, imposing a substantial burden on patients, families, and health systems, particularly in low- and middle-income countries. This review synthesizes current evidence on the epidemiology, pathophysiology, clinical evaluation, and management of ischemic and hemorrhagic stroke, with emphasis on advances incorporated into the most recent American Heart Association/American Stroke Association guidelines. Ischemic stroke, caused by thromboembolic or hypoperfusive occlusion of cerebral vasculature, accounts for approximately two-thirds of incident strokes and is amenable to time-sensitive reperfusion therapies, including intravenous thrombolysis and endovascular thrombectomy. Hemorrhagic stroke, comprising intracerebral and subarachnoid hemorrhage, carries disproportionately high mortality and requires distinct approaches centered on hemostasis, blood pressure control, and, in selected cases, surgical intervention. Secondary prevention strategies that address hypertension, dyslipidemia, diabetes, atrial fibrillation, and lifestyle factors substantially reduce recurrence risk, while structured rehabilitation improves functional outcomes. This review is intended to provide a comprehensive, evidence-based foundation for graduate-level medical trainees and clinician-scientists engaged in stroke-related research and practice.

References

1.Prabhakaran S, Gonzalez NR, Zachrison KS, et al. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke. Stroke. 2026. doi:10.1161/STR.0000000000000513.

2.GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2021. Lancet Neurol. 2024;23(10):973–1003. doi:10.1016/S1474-4422(24)00369-7.

3.Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. Stroke. 2021;52:e364–e467.

4.Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage. Stroke. 2022;53:e282–e361.

5.Hoh BL, Ko NU, Amin-Hanjani S, et al. 2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage. Stroke. 2023;54:e314–e370.

6.Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update. Stroke. 2019;50:e344–e418.

7.Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378:11–21.

8.Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378:708–718.

9.Berkhemer OA, Fransen PSS, Beumer D, et al. A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke. N Engl J Med. 2015;372:11–20.

10.Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data. Lancet. 2016;387:1723–1731.

11.Campbell BCV, Mitchell PJ, Churilov L, et al. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke. N Engl J Med. 2018;378:1573–1582.

12.Menon BK, Buck BH, Singh N, et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT). Lancet. 2022;400:161–169.

13.Yoshimura S, Sakai N, Yamagami H, et al. Endovascular Therapy for Acute Stroke with a Large Ischemic Region. N Engl J Med. 2022;386:1303–1313.

14.Sarraj A, Hassan AE, Abraham MG, et al. Trial of Endovascular Thrombectomy for Large Ischemic Strokes. N Engl J Med. 2023;388:1259–1271.

15.Anderson CS, Heeley E, Huang Y, et al. Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage. N Engl J Med. 2013;368:2355–2365.

16.Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase. Lancet. 2014;384:1929–1935.

17.Feigin VL, Brainin M, Norrving B, et al. World Stroke Organization: Global Stroke Fact Sheet 2022. Int J Stroke. 2022;17:18–29.

18.O’Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE). Lancet. 2016;388:761–775.

Published

2026-10-17